Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Said Price Erosion Contributed to 26-Percent Revenue Slide in Q3

NEW YORK, Oct. 26 (GenomeWeb News) - Sequenom today said that competition and "price erosion" contributed to a fall-off in third-quarter revenue.

 

Product sales in the three months ended Sept. 30 fell 26 percent to $4.8 million from $6.6 million year over year. Total receipts for the period also fell 26 percent, to $5.2 million from $7.2 million one year ago.

 

Sales of the company's flagship MassArray system were "below expectations," Sequenom CFO Steve Zaniboni said in a statement. However, consumables increased 32 percent during the third quarter.

 

"The main causes of this [decline] are increased competition and price erosion in the ultra high throughput gene discovery market," Zaniboni said. He said the company "expect[s] to see an increase in MassArray Compact system installations" as Sequenom "continue[s] to penetrate the molecular medicine market."

 

R&D spending for the third quarter fell 34 percent to $4 million from $6 million year over year, Sequenom said.

 

Net loss narrowed in the quarter to $8.3 million, or $.21 per share, from $8.8 million, or $.22 per share, one year ago.

 

Sequenom said it had around $43.8 million in cash, equivalents, short-term investments and restricted cash as of Sept. 30.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.